Pas de connexion internet — affichage de la version enregistrée de la page.

Revolution Medici…

USUSD
← Vers le Screener

Revolution Medicines, Inc. (US:RVMD) — Biotechnology: Biological Products (No Diagnostic Substances). Nombre de places boursières sur lesquelles les actions de la société sont cotées : 1. Sur cette page : cours et graphique, dividendes, principaux actionnaires et historique du nombre d'actions.

À propos de l'entreprise

Site Web
revmed.com
Relations avec les Investisseurs
revmed.com/investors/
Secteur
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Siège Social
REDWOOD CITY, United States
PDG
Mark A. Goldsmith
Employés
883
Fondée
2014
Actions en Circulation
214.34 M au 2026-07-31
Flottant
184.5 M
Capitalisation Boursière
43.24 Md USD
Initiés
1.85%
Investisseurs Institutionnels
101.01%
Secteur d'Activité (SIC)
Biological Products, (No Diagnostic Substances)
ISIN
US76155X1000
LEI
549300JU3X0LBCQ65892
FCF
−1.23 Md USD
Dette
0
Résultats et FCF — pour les 12 mois à 30.06.2026 (dernier rapport de l'entreprise).
Description

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; and development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C). Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Bourses et Tickers

BourseTickerDevisePrixType
US USA StocksRVMDUSD189.76 +0.87%actions ordinaires

Cours sur 3 Mois

US:RVMD · USD
jour de hausse jour de baisseSurvolez / touchez un jour — cours d'ouverture, de clôture, plus haut et plus bas
publicité

Principaux Actionnaires

DétenteurParticipationActionsDate du Rapport
Blackrock Inc.6.39%13.7 M2026-06-30
Farallon Capital Managem…6.32%13.55 M2026-06-30
FMR, LLC5.69%12.2 M2026-06-30
Baker Bros. Advisors, LP5.34%11.44 M2026-06-30
Jupiter Topco LLC5.01%10.74 M2026-06-30
Darwin Global Management…4.96%10.63 M2026-06-30
Vanguard Capital Managem…4.24%9.09 M2026-06-30
Vanguard Portfolio Manag…3.87%8.29 M2026-06-30
Nextech Invest, Ltd.3.55%7.6 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.99%6.41 M2026-06-30
Paradigm Biocapital Advi…2.97%6.36 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.16%4.63 M2026-06-30
Growth Fund of America1.38%2.96 M2026-06-30
VANGUARD INDEX FUNDS-Van…1.25%2.67 M2026-06-30
Fidelity Mt. Vernon Stre…1.15%2.47 M2026-07-31
BORISY ALEXIS (Director)≈1.09%2.34 M2026-06-18
VANGUARD INDEX FUNDS-Van…1.07%2.29 M2026-06-30
VANGUARD SPECIALIZED FUN…0.86%1.84 M2026-04-30
iShares Trust-iShares Bi…0.65%1.39 M2026-07-31
JPMorgan Trust II-JPMorg…0.54%1.17 M2026-06-30
iShares Trust-iShares Ru…0.51%1.1 M2026-07-31
GOLDSMITH MARK A (Chief…≈0.46%984 2382026-08-21
KELSEY STEPHEN MICHAEL (…≈0.14%291 8762026-09-11
HORN MARGARET A (Chief O…≈0.07%154 6472026-06-17
ANDERS JACK LEE (Chief F…≈0.06%123 2692026-06-24
WANG XIAOLIN (Officer)≈0.05%116 0632026-03-17
LIN WEI (Officer)≈0.05%101 3662026-03-17
HORNING SANDRA (Director…≈0.05%97 7652026-06-18
CISLINI JEFFREY TODD (Ge…≈0.03%55 9072026-08-21
SCHROEDER THILO (Directo…——2024-12-05